Concepedia

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd, M. Wouter Dercksen, F. Van den Berkmortel, TJ Smilde, Agnès J. van de Wouw, Frank Peters, J.M.G.H. van Riel, Natascha A. J. B. Peters,

Annals of Oncology · 2015 · 78 citations · 20 references

DOIFull text

Open access

Concepts

References

20

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

C.W. Elston, Ian O. Ellis · Histopathology · 1991 · 6.1K citations

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

José Baselga, Mario Campone, Martine Piccart et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer

Donald A. Berry, Constance Cirrincione, I. Craig Henderson et al. · JAMA · 2006 · 730 citations · Full text

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

Fátima Cardoso, A. Costa, Larry Norton et al. · Annals of Oncology · 2014 · 537 citations · Full text

The impact of new chemotherapeutic and hormone agents on survival in a population‐based cohort of women with metastatic breast cancer

Stephen Chia, Caroline Speers, Yulia Dyachkova et al. · Cancer · 2007 · 464 citations · Full text